中/EN Contact/Message
Innovate
CABAZITAXEL
CABAZITAXEL
departments:肿瘤科
drug:注射液
Active:CABAZITAXEL
indication:转移性前列腺癌
Licensor:Sandoz, Inc.
Approved Country/Region:美国
Approval time:2023-10-27